SOFIA (Bulgaria), April 9 (SeeNews) - UK-headquartered OptiBiotix Health said on Tuesday that it has signed a three-year distribution agreement with an unnamed company for the exclusive rights to distribute and commercialise OptiBiotix's CE marked medical device - SlimBiome Medical, in Bulgaria.
The agreement grants the distributor exclusive distribution in Bulgaria in return for meeting annual sales targets to retain exclusivity, OptiBiotix Health said in a statement.
"We are pleased to announce this exclusive distribution deal after achieving medical device registration and CE mark for SlimBiome(R) in 2018," Fred Narbel, managing director of OptiBiotix Health's prebiotics division, said.
SlimBiome is used to promote weight loss and will be sold as 30 single dose sachets to pharmacies and wholesalers in Bulgaria.
OptiBiotix Health is a life sciences business specialising in the development of compounds tackling obesity, high cholesterol and diabetes.